Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New High-Tech glasses could help kids with low vision read better

NCT ID NCT07336069

First seen Jan 13, 2026 · Last updated Jun 22, 2026 · Updated 24 times

Summary

This study tested a head-mounted device called the Shilangqing Smart Reading Aid, which uses XR and AI to help children with low vision read more easily. 120 children aged 6-18 used the device for 12 weeks, and researchers measured reading speed, accuracy, and eye comfort compared to using traditional magnifiers. The goal is to see if this device is a safe and effective tool to improve reading and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW VISION AIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing Tongren Eye Center

    Beijing, 100730, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Shilangqing Smart Reading Aid (head-mounted XR/AI device)

What this could lead to

If successful, this device could offer a more effective and comfortable way for children with low vision to read, potentially improving their learning and quality of life.

What could go wrong

This is a completed early-stage study with only 120 participants, so results may not apply to all children. The device may cause motion sickness or eye strain in some users.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.